ARCpoint

ARCpoint FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of ARCpoint (ARC.V) as of Oct 24, 2026 is 60.67 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -190.93 % — a change of -131.77% (higher).

FCF Conversion

60.67 %

YoY

-131.77%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of ARCpoint is 2025 60.67 % . FCF Conversion Rate (FCF/EBITDA) of ARCpoint was 2024 -190.93 % . It decreases by -131.77% higher compared to the previous year.

The ARCpoint FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2021
85.33 USD
Jan 1, 2022
20.56 USD
Jan 1, 2023
52.43 USD
Jan 1, 2024
-190.93 USD
Jan 1, 2025
60.67 USD
The ARCpoint FCF Conversion history
YEARFCF ConversionYoY
60.67 %-131.77%
-190.93 %-464.17%
52.43 %+154.98%
20.56 %-75.90%
85.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ARCpoint Stock analysis

What does ARCpoint do? ARCpoint, Inc. generates revenue through its franchise system, which includes drug testing, alcohol screening, DNA, and clinical lab testing services. The ARCpoint Franchise segment sells franchises to individuals across the United States, providing marketing, technology, and training support. The AFG Services segment offers clinical testing, software services, and diagnostic testing kits to franchisees and other business-to-business customers. The Other segment operates corporate-owned labs that serve businesses, physicians, and customers directly. Revenue streams include franchise fees, sales of diagnostic kits, and corporate lab services. ARCpoint Franchise segment revenue comes from franchise sales and ongoing support services. AFG Services segment revenue is derived from clinical testing, software services, and direct sales of diagnostic kits to business customers. Corporate-owned labs in the Other segment provide clinical and diagnostic services to businesses, physicians, and end customers, contributing to overall revenue. The company's business model relies on a mix of franchise sales, service offerings, and direct B2B transactions. The company's primary customers are individuals purchasing franchises, businesses requiring clinical testing, and physicians seeking diagnostic services. Franchisees benefit from ARCpoint's marketing, technology, and training support. AFG Services targets businesses needing diagnostic kits and software solutions. Corporate-owned labs serve businesses, physicians, and end customers with comprehensive testing solutions. Revenue is generated through multiple channels within the company's segmented structure. ARCpoint is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ARCpoint stock

FCF Conversion Rate (FCF/EBITDA) of ARCpoint is 60.67 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of ARCpoint changed from -190.93 % to 60.67 %, representing a -131.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) ARCpoint since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s ARCpoint with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ARCpoint

All Key Metrics — ARCpoint